|
SKIV2L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.153700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.596400E-03 |
| Normal-vs-Stage2 |
4.706000E-01 |
| Normal-vs-Stage3 |
1.72376999999502E-05 |
| Normal-vs-Stage4 |
2.399400E-04 |
| Stage1-vs-Stage2 |
4.434400E-01 |
| Stage1-vs-Stage3 |
9.575800E-03 |
| Stage1-vs-Stage4 |
3.408100E-02 |
| Stage2-vs-Stage3 |
3.763900E-02 |
| Stage2-vs-Stage4 |
4.730400E-02 |
| Stage3-vs-Stage4 |
9.246800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.781700E-04 |
| Normal-vs-AfricanAmerican |
1.59020000001231E-06 |
| Normal-vs-Asian |
4.668000E-02 |
| Caucasian-vs-AfricanAmerican |
7.861600E-03 |
| Caucasian-vs-Asian |
5.603400E-01 |
| AfricanAmerican-vs-Asian |
7.754800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.578230E-04 |
| Normal-vs-Female |
5.076200E-03 |
| Male-vs-Female |
4.153400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.0438000000016E-05 |
| Normal-vs-Age(41-60Yrs) |
2.221300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.718300E-03 |
| Normal-vs-Age(81-100Yrs) |
8.745800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.426830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.190500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.520000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.749000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.890800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.709600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.502600E-01 |
| Normal-vs-Grade 2 |
4.208300E-02 |
| Normal-vs-Grade 3 |
2.996000E-04 |
| Normal-vs-Grade 4 |
2.42729999988534E-07 |
| Grade 1-vs-Grade 2 |
7.191600E-01 |
| Grade 1-vs-Grade 3 |
2.975000E-01 |
| Grade 1-vs-Grade 4 |
2.469700E-02 |
| Grade 2-vs-Grade 3 |
5.394000E-02 |
| Grade 2-vs-Grade 4 |
8.34560000000373E-05 |
| Grade 3-vs-Grade 4 |
1.174350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.915200E-01 |
| Normal-vs-ccB subtype |
6.08469999940908E-08 |
| ccA subtype-vs-ccB subtype |
3.03850000715755E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.919100E-03 |
| Normal-vs-N1 |
4.083700E-03 |
| N0-vs-N1 |
2.592400E-01 |
|
|
